21
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Hepatic lipid peroxidation, sulfhydryl status, and toxicity of the blue‐green algal toxin microcystin‐LR in mice

, , &
Pages 71-91 | Received 12 Nov 1989, Accepted 30 Mar 1990, Published online: 20 Oct 2009
 

Abstract

Microcystin‐LR (MCLR), a cyclic heptapeptide produced by the blue‐green algae Microcystis aeruginosa, produces death in female mice treated with 100 μg MCLR/kg. Kupffercell hyperplasia was observed histologically after treatment with 50 or 100 μg MCLR/kg. No other changes or lethality were observed with the 50 μg MCLR/kg, while 100% lethality occurred in less than 2 h in mice treated with 100 μg/kg. In these animals liver weights increased by 45% and hepatic hemoglobin content increased 106% at 60 min posttreatment. Liver histology showed loss of hepatic architecture and necrosis 30 min after treatment, and congestion with blood became evident at 45 min after treatment. Serum enzymes were significantly increased 45 min posttreatment. Hepatic nonprotein sulfhydryl content decreased 19% when calculated on the basis of cytosolic protein and 39% when based upon the total protein content, respectively. The sulfhydryl content of the liver cytoskeletal fraction decreased 26% by 30 min after treatment. Decreased enzyme‐mediated and increased non‐enzyme‐mediated lipid peroxidation were observed in hepatic microsomes following both in vivo and in vitro exposure of hepatic microsomes to MCLR. The toxicity of MCLR may be related to alterations in the sulfhydryl content of the cytoskeletal protein. Furthermore, MCLR may either directly or indirectly affect microsomes, suggesting alterations in structure and function of smooth endoplasmic reticulum.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.